Evidence map›Paper›PMID 42332139›Full record

ArticleNPJ digital medicine2026

Handling missing modalities in multimodal survival prediction for non-small cell lung cancer.

Filippo Ruffini, Camillo Maria Caruso, Claudia Tacconi, Lorenzo Nibid, Francesca Miccolis, Marta Lovino, Carlo Greco, Edy Ippolito, Michele Fiore, Alessio Cortellini and 9 more

Abstract read
PubMed Publisher
In one paragraph

Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Filippo Ruffini *Unit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy. filippo.ruffini@unicampus.it.
Camillo Maria Caruso *Unit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy.
Claudia TacconiOperative Research Unit of Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Lorenzo NibidAnatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Francesca MiccolisDepartment of Engineering 'Enzo Ferrari', University of Modena and Reggio Emilia, Modena, Italy.
Marta LovinoDepartment of Engineering 'Enzo Ferrari', University of Modena and Reggio Emilia, Modena, Italy.
Carlo GrecoOperative Research Unit of Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Edy IppolitoOperative Research Unit of Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Michele FioreOperative Research Unit of Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Alessio CortelliniDepartment of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
Bruno Beomonte ZobelOperative Research Unit of Radiology and Interventional Radiology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Giuseppe PerroneAnatomical Pathology Operative Research Unit, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Bruno VincenziDepartment of Medicine and Surgery, Università Campus Bio-Medico di Roma, Rome, Italy.
Claudio MarroccoUniversity of Cassino and Southern Lazio, Cassino, Italy.
Alessandro BriaUniversity of Cassino and Southern Lazio, Cassino, Italy.
Elisa FicarraDepartment of Engineering 'Enzo Ferrari', University of Modena and Reggio Emilia, Modena, Italy.
Sara RamellaOperative Research Unit of Radiation Oncology, Fondazione Policlinico Universitario Campus Bio-Medico di Roma, Rome, Italy.
Valerio GuarrasiUnit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy. valerio.guarrasi@unicampus.it.
Paolo SodaUnit of Artificial Intelligence and Computer Systems, Department of Engineering, Università Campus Bio-Medico di Roma, Rome, Italy. paolo.soda@umu.se.

Funding

Kempestiftelserna JCSMK24-0094Ministero dell'Università e della Ricerca 20228MZFAA-AIDAMinistero dell'Università e della Ricerca PE0000013-FAIRMinistero dell'Università e della Ricerca, Italy 20228MZFAA-AIDAUniversità Campus Bio-Medico di Roma GEN0469
6 · The paper itself

Abstract

Accurate survival prediction in non-small cell lung cancer (NSCLC) requires integrating clinical, radiological, and histopathological data. Multimodal deep learning (MDL) can improve precision prognosis, but small cohorts and missing modalities limit its clinical applicability, as conventional approaches enforce complete-case filtering or imputation. We present a missing-aware multimodal survival framework that combines computed tomography (CT), whole-slide histopathology images (WSI), and structured clinical variables for overall survival modeling in unresectable stage II-III NSCLC. The framework uses foundation models (FMs) for modality-specific feature extraction and a missing-aware encoding strategy that enables intermediate multimodal fusion under naturally incomplete modality profiles. By design, the architecture processes all available data without dropping patients during training or inference. Intermediate fusion outperforms unimodal baselines and both early and late fusion strategies, with the trimodal configuration reaching a C-index of 74.42. Modality-importance analyses show that the fusion model adapts its reliance on each data stream according to representation informativeness, shaped by the alignment between FM pretraining objectives and the survival task. The learned risk scores produce clinically meaningful stratification of disease progression and metastatic risk, with statistically significant log-rank tests across all modality combinations, supporting the translational relevance of the proposed framework.

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.